| abstract |
The present invention relates to a 2-amino-N-[2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydropyridyl A new crystalline form of oxazo[4,3-c]pyridin-5-yl)-1-(R)-benzyloxymethyl-2-oxo-ethyl]-isobutylamine L-tartrate. More specifically, the present invention relates to a polymorphic form, and further to a method of producing the polymorphic form, a composition comprising the polymorphic form, and uses thereof. |